News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
test biolan
BIOLAN has launched its rapid serological test for the detection of antibodies against COVID-19 with a guaranteed industrial production capacity
The Basque SME located in Zamudio has invested heavily to equip itself with the equipment that will…
logo oryzon
ORYZON presents vafidemstat 12-month clinical data from its Phase IIa clinical trials ETHERAL and REIMAGINE-AD in Alzheimer’s at the virtual AD/PD-2021 conference
Mujeres 8M2021
Report: Spanish women lead the charge against Covid-19
Coronavirus
Drugs, vaccines and diagnostic tests are being developed by women in the biotechnology sector, who…
ADCC
Drug Developers Can Measure ADCC in Biologically Relevant Systems with New Promega Bioluminescent Primary Cell Bioassay
Promega PBMC ADCC Bioassay combines physiologically representative primary cells with reliable…
Partners - Promega
ana polanco biospain 3 marzo
AseBio announces that BIOSPAIN, Spain's leading biotech event, will be held at the end of September this year
BioSpain
BIOSPAIN will be held at the Palacio de Congresos y Auditorio de Navarra-Baluarte in Pamplona, from…
reportaje CRISPR
Report: Why is it important to get on the innovation train with CRISPR?
Gene editing
Cancer, infectious and genetic diseases, sustainable food for all, drought-resistant plants, the…
foto
SIEMENS HEALTHINEERS Y IUL SA, una nueva alianza para combatir la COVID-19
The IUL’s reader, so-called iPeak®, capture, and process the image of the test guaranteeing the…
fondo capital riesgo
AseBio brings together top specialized venture capital managers to drive biotech sector
Financing
Seven venture capital managers that specialize in the life sciences set up new workgroup as a key…
Logo de Oryzon
ORYZON announces FDA Orphan Drug Designation granted to iadademstat for treatment of Acute Myeloid Leukemia
The compound is currently in Phase II Now has orphan designation in both U.S. and EU